Profile - To The Moon

JTMC1982

Jeniffer Tan Bee Chen

Posts · 13Posts · 13
Following · 0Following · 0
Followers · 0Followers · 0

- JTMC1982JTMC1982
  ·2024-11-21
  $CAROTE(02549)$ How is this share?
  1.44K Comment
  Like
  Share
  Report
- JTMC1982JTMC1982
  ·2024-11-21
  $CHINAGOLDINTL(02099)$ This is scam stock as well. Run ASAP
  1.54K Comment
  Like
  Share
  Report
- JTMC1982JTMC1982
  ·2024-11-20
  $KINGFARPROPERTY(01354)$ This is scammers. Be careful
  2.65K 4
  1
  Share
  Report
- JTMC1982JTMC1982
  ·2024-11-14
  $CN Energy Group Inc.(CNEY)$ Any hope? Still can holding this share?
  2.17K 1
  2
  Share
  Report
- JTMC1982JTMC1982
  ·2024-11-01
  How's the EC Healthcare? Still have opportunities to increase the share price?
  EC Healthcare (2138 HK): Shares at Multi-Year Low; Still Not a Value Buying Opportunity
  utm_source=tiger_community
  EC Healthcare (2138 HK): Shares at Multi-Year Low; Still Not a Value Buying Opportunity
  1.67K Comment
  Like
  Share
  Report
- JTMC1982JTMC1982
  ·2024-10-08
  $EC HEALTHCARE(02138)$
  1.35K Comment
  Like
  Share
  Report
- JTMC1982JTMC1982
  ·2021-07-13
  $ContextLogic Inc.(WISH)$Look like the price will be ard $10.98~$11.05 and then up down up down still the same price…. Rubbish share
  1.66K Comment
  2
  Share
  Report
- JTMC1982JTMC1982
  ·2021-07-04
  $ContextLogic Inc.(WISH)$What’s going on…… please settle your disputes as fast so possible….
  1.84K Comment
  Like
  Share
  Report
- JTMC1982JTMC1982
  ·2021-06-18
  Oh no
  Orphazyme shares tumbled more than 60% in pre-market trading
  Orphazyme shares tumbled more than 60% in pre-market trading. Orphazyme slashed its financial foreca
  Orphazyme shares tumbled more than 60% in pre-market trading
  1.77K Comment
  4
  Share
  Report
- JTMC1982JTMC1982
  ·2021-06-17
  ?‍♀️
  Sorry, this post has been deleted
  1.64K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3582752686761306","uuid":"3582752686761306","gmtCreate":1622428174274,"gmtModify":1623895973198,"name":"JTMC1982","pinyin":"jtmc1982","introduction":"","introductionEn":null,"signature":"Jeniffer Tan Bee Chen","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":20,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":373385613205512,"gmtCreate":1732194589271,"gmtModify":1732194593525,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/02549\">$CAROTE(02549)$</a> How is this share?","listText":"<a href=\"https://ttm.financial/S/02549\">$CAROTE(02549)$</a> How is this share?","text":"$CAROTE(02549)$ How is this share?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/373385613205512","isVote":1,"tweetType":1,"viewCount":1443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373191059738944,"gmtCreate":1732156583385,"gmtModify":1732156587081,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/02099\">$CHINAGOLDINTL(02099)$</a> This is scam stock as well. Run ASAP","listText":"<a href=\"https://ttm.financial/S/02099\">$CHINAGOLDINTL(02099)$</a> This is scam stock as well. Run ASAP","text":"$CHINAGOLDINTL(02099)$ This is scam stock as well. Run ASAP","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/373191059738944","isVote":1,"tweetType":1,"viewCount":1544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372971652640920,"gmtCreate":1732067508679,"gmtModify":1732067512301,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/01354\">$KINGFARPROPERTY(01354)$</a> This is scammers. Be careful&nbsp;","listText":"<a href=\"https://ttm.financial/S/01354\">$KINGFARPROPERTY(01354)$</a> This is scammers. Be careful&nbsp;","text":"$KINGFARPROPERTY(01354)$ This is scammers. Be careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/372971652640920","isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4131703342800552","authorId":"4131703342800552","name":"neo26000","avatar":"https://community-static.tradeup.com/news/11d50ec0d6202770a8629aa7f06a5d4f","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"4131703342800552","idStr":"4131703342800552"},"content":"They asked the group to buy at 17.50 and to sell at 22.30 back to them...like washing the stock. Subsequently, my group do not talk about this stock anymore.","text":"They asked the group to buy at 17.50 and to sell at 22.30 back to them...like washing the stock. Subsequently, my group do not talk about this stock anymore.","html":"They asked the group to buy at 17.50 and to sell at 22.30 back to them...like washing the stock. Subsequently, my group do not talk about this stock anymore."},{"author":{"id":"4131703342800552","authorId":"4131703342800552","name":"neo26000","avatar":"https://community-static.tradeup.com/news/11d50ec0d6202770a8629aa7f06a5d4f","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"4131703342800552","idStr":"4131703342800552"},"content":"Scammers alreadt told me to sell at 22.30 last week.No idea who is buying.","text":"Scammers alreadt told me to sell at 22.30 last week.No idea who is buying.","html":"Scammers alreadt told me to sell at 22.30 last week.No idea who is buying."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370618848268640,"gmtCreate":1731522245408,"gmtModify":1731522248931,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a> Any hope? Still can holding this share?","listText":"<a href=\"https://ttm.financial/S/CNEY\">$CN Energy Group Inc.(CNEY)$</a> Any hope? Still can holding this share?","text":"$CN Energy Group Inc.(CNEY)$ Any hope? Still can holding this share?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/370618848268640","isVote":1,"tweetType":1,"viewCount":2174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366418112069656,"gmtCreate":1730465857089,"gmtModify":1730465860672,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"How's the EC Healthcare? Still have opportunities to increase the share price?","listText":"How's the EC Healthcare? Still have opportunities to increase the share price?","text":"How's the EC Healthcare? Still have opportunities to increase the share price?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366418112069656","repostId":"2450007653","repostType":2,"repost":{"id":"2450007653","kind":"highlight","weMediaInfo":{"introduction":"Smartkarma","home_visible":1,"media_name":"Smartkarma","id":"1009381084","head_image":"https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07"},"pubTimestamp":1720546879,"share":"https://ttm.financial/m/news/2450007653?lang=&edition=fundamental","pubTime":"2024-07-10 01:41","market":"hk","language":"en","title":"EC Healthcare (2138 HK): Shares at Multi-Year Low; Still Not a Value Buying Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2450007653","media":"Smartkarma","summary":"utm_source=tiger_community","content":"<html><body><img src=\"https://static-prod.smartkarma.com/insight_cover_images/180f8232-2175-412c-9e77-174c9e170c0e.png\"/>\n<p>⬇  <a href=\"https://laohu8.com/S/02138\">EC Healthcare</a> - EC Healthcare reported muted FY24 result with sales up 9% but EBITDA and net profit down. Cost pressure and economic challenges contribute to uncertainties. Shares dropped 70% in the last one year.</p><br/><p>Continue reading on Smartkarma:- https://www.smartkarma.com/insights/ec-healthcare-2138-hk-shares-at-multi-year-low-still-not-a-value-buying-opportunity?utm_source=tiger_community</p><p>By Tina Banerjee, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/tina-banerjee?utm_source=tiger_community</p><p>On EC Healthcare (02138):- https://www.smartkarma.com/entities/ec-healthcare?utm_source=tiger_community</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EC Healthcare (2138 HK): Shares at Multi-Year Low; Still Not a Value Buying Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEC Healthcare (2138 HK): Shares at Multi-Year Low; Still Not a Value Buying Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1009381084\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/bb92df7ff435380d798b36afa44a5c07);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Smartkarma </p>\n<p class=\"h-time\">2024-07-10 01:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><img src=\"https://static-prod.smartkarma.com/insight_cover_images/180f8232-2175-412c-9e77-174c9e170c0e.png\"/>\n<p>⬇  <a href=\"https://laohu8.com/S/02138\">EC Healthcare</a> - EC Healthcare reported muted FY24 result with sales up 9% but EBITDA and net profit down. Cost pressure and economic challenges contribute to uncertainties. Shares dropped 70% in the last one year.</p><br/><p>Continue reading on Smartkarma:- https://www.smartkarma.com/insights/ec-healthcare-2138-hk-shares-at-multi-year-low-still-not-a-value-buying-opportunity?utm_source=tiger_community</p><p>By Tina Banerjee, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/tina-banerjee?utm_source=tiger_community</p><p>On EC Healthcare (02138):- https://www.smartkarma.com/entities/ec-healthcare?utm_source=tiger_community</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.smartkarma.com/home/private-investor-solutions/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2450007653","content_text":"⬇  EC Healthcare - EC Healthcare reported muted FY24 result with sales up 9% but EBITDA and net profit down. Cost pressure and economic challenges contribute to uncertainties. Shares dropped 70% in the last one year.Continue reading on Smartkarma:- https://www.smartkarma.com/insights/ec-healthcare-2138-hk-shares-at-multi-year-low-still-not-a-value-buying-opportunity?utm_source=tiger_communityBy Tina Banerjee, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/tina-banerjee?utm_source=tiger_communityOn EC Healthcare (02138):- https://www.smartkarma.com/entities/ec-healthcare?utm_source=tiger_community","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":357802865750208,"gmtCreate":1728374538175,"gmtModify":1728374540996,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/02138\">$EC HEALTHCARE(02138)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/02138\">$EC HEALTHCARE(02138)$</a>&nbsp;","text":"$EC HEALTHCARE(02138)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357802865750208","isVote":1,"tweetType":1,"viewCount":1354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145935096,"gmtCreate":1626185617815,"gmtModify":1703755102970,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>Look like the price will&nbsp;be ard&nbsp;$10.98~$11.05 and&nbsp;then up down up down still the same price…. Rubbish share","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>Look like the price will&nbsp;be ard&nbsp;$10.98~$11.05 and&nbsp;then up down up down still the same price…. Rubbish share","text":"$ContextLogic Inc.(WISH)$Look like the price will be ard $10.98~$11.05 and then up down up down still the same price…. Rubbish share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145935096","isVote":1,"tweetType":1,"viewCount":1663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155191493,"gmtCreate":1625383931112,"gmtModify":1703741122517,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>What’s&nbsp;going on…… please&nbsp;settle your disputes as fast so possible….","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>What’s&nbsp;going on…… please&nbsp;settle your disputes as fast so possible….","text":"$ContextLogic Inc.(WISH)$What’s going on…… please settle your disputes as fast so possible….","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155191493","isVote":1,"tweetType":1,"viewCount":1842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166607935,"gmtCreate":1624004745027,"gmtModify":1703826322386,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166607935","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":1771,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161609009,"gmtCreate":1623920301401,"gmtModify":1703823525868,"author":{"id":"3582752686761306","authorId":"3582752686761306","name":"JTMC1982","avatar":"https://static.tigerbbs.com/15b270f98d2377c6cc6f6662a939b1ed","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3582752686761306","idStr":"3582752686761306"},"themes":[],"htmlText":"?‍♀️","listText":"?‍♀️","text":"?‍♀️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161609009","repostId":"2143794095","repostType":4,"isVote":1,"tweetType":1,"viewCount":1636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}